Dr. Robert Bristow, MD of Princess Margaret Cancer Centre discusses molecular markers have greater impact on risk of recurrence than cancer stage and PSA levels at ASCO GU 2016
Advertisement
Molecular markers have greater impact on risk of recurrence than cancer stage and PSA levels
By Editor